Director, Global Access Strategy & Pricing, Vepdegestrant

ROLE SUMMARY

The Global Access Strategy and Pricing (GASP) Director role directly impacts the ability to achieve business objectives by supporting the development of strategic guidance on access, pricing, optimal reimbursement, launch sequencing, patient value, and evidence generation for Vepdegestrant in preparation for launch and with consideration for subsequent indications. Vepdegestrant is an Alliance product with Arvinas. In collaboration with the Vepdegestrant GASP Lead, the asset development team, and Arvinas partners, the Director will support the development of the market access and pricing strategy, including launch GPA, and support the generation and synthesis of global payer insights, recommendations for clinical trial design for subsequent indications, and development of financial models to evaluate the impact of lifecycle indications and combinations within the Breast cancer portfolio.

This position will function with a 'One Global Access and Value' mindset and work in a closely aligned manner with the the Vepdegestrant GASP Lead, and other GAV colleagues (USMA, HV&E). This role will support the advancement of the integrated value and access strategy (IVAS) in partnership with the cross functional team and Alliance partners, that is aligned to the brand strategy and optimizes the long term value of Vepdegestrant within the context of the breast cancer franchise. The position reports to the GASP Breast Cancer Team Lead within GAV.

• Lead generation of payer insights and support the translation into clear and cohesive integrated value and access, pricing and evidence generation strategies for key markets to support Vepdegestrant.
• Provide subject matter expertise and support critical strategic discussions at Senior Leadership forums.
• Support Global cross functional and local preparation of Vepdegestrant EU JCA readiness in close partnership with HV&E
• Support shaping breast cancer lifecycle management leveraging expertise in access and price strategies.
• Deliver clear recommendations relating to payer strategy, pricing and reimbursement, evidence generation, data collection and value proposition.
• Participation in virtual cross functional teams including representing GAV at the GPT, and at Alliance meetings. When necessary, coordinate and lead projects related to specific asset threats and opportunities.

• Maintain in-depth understanding of payer regulations, needs of all types of payers (e.g. HTA agencies, institutions and patients) in key Pfizer markets.
• Knowledgeable about US Oncology Access & Pricing Landscape, IDM Markets, China, HTA/Payer requirements and EU JCA.
• Support assessment and communication of external access trends to anticipate potential challenges and opportunities for Vepdegestrant
• Gather and synthesize feedback for development programs with health technology assessment agencies, payers, and relevant patient associations.

• Support the development of clear and cohesive access, pricing and evidence generation strategy to optimize value of Vepdegestrant .
• Lead discussions with Country Health & Value and Payer Channel Access Leads at critical junctures to ensure local insights are integrated into global plans that optimize long-term value for Vepdegestrant
• Provide input into clinical development plans, market access and pricing strategies and recommendations, early HTA advice, early economic models, and evidence generation plans via the Integrated Value & Access Plan.
• Support alignment efforts with Commercial, BAI, Clinical, Medical, Asset teams, and the Alliance to ensure clinical trial design and commercial strategies reflect payer insights and align with Bold Moves in order to maximize value of Vepdegestrant.
• Support discussions and early buy-in discussions with senior leadership on price and market access strategy and recommendations to support key business decision points.
• Support development of the value proposition and value-based agreement strategy and buy-in from cross-functional stakeholders.
• Develop launch deliverables and deliver training for Pfizer and the Alliance such as Value Story, Objection Handler, Launch Readiness, Mock Negotiations
• Support analyses and recommendations in partnership with the Vepdegestrant GASP Lead and HV&E to influence clinical trial design recommendations (e.g. endpoints, comparators, PROs), development of early economic model, and generation of supplemental evidence (e.g. comparative-effectiveness studies leveraging real-world evidence) to strengthen our value proposition and pricing/access opportunity.

• Build and maintain relationships with cross-functional teams including HEOR, Medical, Commercial, BAI and others to drive payer perspective and optimize for reimbursability per critical business needs globally for breast cancer.
• Work efficiently and collaboratively in a highly matrixed environment.
• Develop expertise in US, IDM, China markets and launch requirements.

• Bachelor's degree minimum required.
• 10 years of experience required with Bachelor's; 9 years of experience required with Master's / MBA; 7 years of experience required with PharmD / PhD, preferably in pharmaceutical industry or related consulting services, sufficient to have developed an understanding of the global and US payer and market access environment.
• Experience in developing and executing Pricing & Market Access strategies and deliverables on US and key ex-US markets such as Germany, France, UK, Italy and/or Spain, China, Japan.
• Excellent oral and written English communication skills required

• Advanced degree in a healthcare, business or economic field preferred (PH.D, MD or MBA)
• Experience working in beast cancer agents globally, and knowledge of HTA and Payer requirement is desirable. US, IDM, China, country level HTA and negotiation experience is desirable.
• Strong knowledge and understanding of drug development process.
• Pharmaceutical business, including experience in strategy development and interaction with customers.
• Strong project management abilities (contracting, budgeting, vendor management) essential.
• Demonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines and rapidly shifting priorities.
• Excellent interpersonal skills required; ability to understand and respond to multiple internal and external customers and influence in a matrix environment.
• Skilled in functioning within a matrix organization where managing through influence is required and experience of managing people in a cross-cultural environment.

• Last Date to Apply for Job: August 14th, 2024.
• Eligible for employee referral bonus
• Position is hybrid and will require to work 2 to 3 days per week from site
• Ability to travel depending on business needs